Literature DB >> 2780657

Epirubicin in treatment and recurrence prophylaxis of patients with superficial bladder cancer.

K Burk1, K H Kurth, D Newling.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2780657

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN： 0361-7742


× No keyword cloud information.
  4 in total

Review 1.  Current recommendations for the management of bladder cancer. Drug therapy.

Authors:  J A Witjes
Journal:  Drugs       Date:  1997-03       Impact factor: 9.546

2.  A randomized trial of early intravesical instillation of epirubicin in superficial bladder cancer. The Nagoya University Urological Oncology Group.

Authors:  K Okamura; T Murase; K Obata; S Ohshima; Y Ono; T Sakata; Y Hasegawa; T Shimoji; K Miyake
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

3.  Intravesical epirubicin in the prophylaxis of superficial bladder cancer.

Authors:  F Sengör; M Beysel; K Erdoğan; A Erol; D Tuzluoğlu
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370

4.  Intravesical therapy for urothelial carcinoma of the bladder.

Authors:  M Manoharan
Journal:  Indian J Urol       Date:  2011-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.